GMIP can influence its functional state through various signaling pathways and phosphorylation events. Forskolin is known to directly stimulate adenylyl cyclase, which leads to an increase in intracellular cAMP levels. The elevated cAMP activates protein kinase A (PKA), which can target GMIP for phosphorylation, leading to its activation. Similarly, PMA activates protein kinase C (PKC), another kinase that can phosphorylate GMIP, thus altering its activity state. Ionomycin, by increasing intracellular calcium levels, possibly engages calcium-dependent kinases that are capable of phosphorylating GMIP, thereby activating it. Epidermal Growth Factor (EGF), upon binding to its receptor, triggers the MAPK/ERK signaling cascade, which is known to target various proteins for phosphorylation, including GMIP. Insulin, through its receptor's influence, can activate the PI3K/Akt signaling pathway, further contributing to the phosphorylation and consequent activation of GMIP.
In the presence of oxidative stress, molecules like hydrogen peroxide can serve as secondary messengers, leading to the activation of redox-sensitive kinases, which may result in the phosphorylation and activation of GMIP. Bradykinin, through its receptor-mediated activation of phospholipase C (PLC), leads to PKC activation, which is another pathway through which GMIP can be phosphorylated and activated. Anisomycin acts as an activator of the MAPK pathway, leading to the activation of kinases that can phosphorylate GMIP. Inhibitors of protein phosphatases such as Calyculin A and Okadaic Acid prevent dephosphorylation of proteins, which can result in the sustained phosphorylation and activation of GMIP. Dibutyryl-cAMP, a cAMP analog, activates PKA, which can lead to the phosphorylation and activation of GMIP. Lastly, Lithium Chloride's inhibition of GSK-3 may lead to the activation of pathways that culminate in the phosphorylation and activation of GMIP, illustrating the complex interplay of kinase and phosphatase activities in regulating protein function
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can phosphorylate GMIP, resulting in its functional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as an ionophore and increases intracellular calcium levels, potentially leading to the activation of calcium-dependent kinases that can phosphorylate and activate GMIP. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin receptor activation stimulates PI3K/Akt signaling pathway, which can result in the phosphorylation and activation of downstream targets including GMIP. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Hydrogen peroxide acts as a signaling molecule and can lead to the activation of redox-sensitive kinases that may phosphorylate and activate GMIP. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin receptor engagement activates PLC, leading to PKC activation, which can phosphorylate and activate GMIP. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a potent activator of the MAPK pathway, which can lead to the activation of GMIP through phosphorylation by MAPK-interacting kinases. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 and 2A, which can lead to increased phosphorylation and activation of proteins including GMIP by preventing their dephosphorylation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Similar to Calyculin A, Okadaic Acid inhibits protein phosphatases, leading to increased phosphorylation levels and potential activation of GMIP. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA, which can phosphorylate and lead to the activation of GMIP. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3, which might lead to the activation of pathways that result in the phosphorylation and activation of GMIP. | ||||||